Author

A. Jin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Research Focus:host-pathogen & immune response· 5 Assay:proteomics· 5 Organism:human· 3 Organism:virus· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:clustering· 1

Frequent Co-Authors

C. Hu· 5 shared M. Shen· 5 shared T. Li· 5 shared W. Wang· 5 shared X. Han· 5 shared Y. Wang· 5 shared A. Huang· 4 shared F. Gao· 4 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

C. Hu

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

A cocktail containing two synergetic antibodies broadly neutralizes SARS-CoV-2 and its variants including Omicron BA.1 and BA.2

X. Zhang, F. Luo, H. Zhang, H. Guo, J. Zhou, T. Li, S. Chen, S. Song, M. Shen, Y. Wu, Y. Gao, X. Han, Y. Wang, C. Hu, Y. Lu, , A. Huang

This paper identifies a potent antibody cocktail that synergistically neutralizes SARS-CoV-2 and its variants, including Omicron BA.1 and BA.2.

bioRxiv · Apr 26, 2022 · PreprintImmunology

Mismatch repair deficiency is not sufficient to increase tumor immunogenicity

P. M. K. Westcott, F. Muyas, O. Smith, H. Hauck, N. J. Sacks, Z. A. Ely, A. M. Jaeger, W. M. Rideout, A. Bhutkar, D. Zhang, M. C. Beytagh, D. A. Canner, R. T. Bronson, S. Naranjo, A. Jin, , T. Jacks

This study shows that MMRd in mouse tumor models does not increase immunogenicity or ICB response, due to intratumoral heterogeneity.

bioRxiv · Aug 24, 2021 · PreprintCancer Biology

Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants

T. Li, X. Han, C. Gu, H. Guo, H. Zhang, Y. Wang, C. Hu, K. Wang, F. Liu, F. Luo, Y. Zhang, J. Hu, W. wang, S. Li, Y. Hao, , A. Jin

This study identifies three ultrapotent SARS-CoV-2 neutralizing antibodies effective against B.1.351 variants, showing synergistic effects and protective efficacy in mice.

bioRxiv · Apr 19, 2021Immunology

Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants

C. Hu, M. Shen, X. Han, Q. Chen, L. Li, S. Chen, J. Zhang, F. Gao, W. Wang, Y. Wang, T. Li, S. Li, J. Huang, J. Wang, J. Zhu, , A. Jin

The paper identifies cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 epitope and its variants, showing their ability to activate and kill infected cells.

bioRxiv · Nov 2, 2020Immunology

A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD

T. Li, X. Han, Y. Wang, C. Gu, J. Wang, C. Hu, S. Li, K. Wang, F. Luo, J. Huang, Y. Long, S. Song, W. Wang, J. Hu, R. Wu, , A. Jin

This study identifies a linear epitope on SARS-CoV-2 S-RBD recognized by a potent neutralizing antibody and shows its potential for vaccine design.

bioRxiv · Sep 11, 2020 · PreprintImmunology

A rapid and efficient screening system for neutralizing antibodies and its application for the discovery of potent neutralizing antibodies to SARS-CoV-2 S-RBD

X. Han, Y. Wang, S. Li, C. Hu, T. Li, C. Gu, K. Wang, M. Shen, J. Wang, J. Hu, R. Wu, S. Mu, F. Gong, Q. Chen, F. Gao, , A. Jin

This paper introduces a rapid screening system to identify potent neutralizing antibodies against SARS-CoV-2 and demonstrates its effectiveness in discovering high-potency antibodies.

bioRxiv · Aug 19, 2020Immunology